Table 1. B cell subsets surface markers and corresponding compartments in MS.
Up-to-date reported B-cell subtypes with reference to the B cell lineage in MS . Sub-types from other inflammatory conditions are also mentioned. 88 Abbreviations : SLO: secondary lymphoid organ; GC: germinal center; BM: bone marrow; ASC: antibody secreting cells; LLPC: long lived plasma cells. ‘Compartment’ makes reference to the organ where the biomarkers were found.
| B-cell subtype | Surface biomarkers | Compartment | Reference |
|---|---|---|---|
| Stem cell | CD34, HLA-DR | BM | 12 |
| Pro-B cell | CD19 +CD34 +IgM - | BM | 20 |
| CD34, HLA-DR, CD19 | BM | 12 | |
| Pre-B cell | HLA-DR, CD19, CD20, Pre-BCR | BM | 12 |
| CD19 +CD34 +IgM - | BM | 20 | |
| Immature B cell | HLA-DR, CD19, CD20, IgM | BM | 12 |
| Transitional B cells | CD19 +CD27 -CD38 hiCD24 hi | Blood | 27 |
| HLA-DR, CD19, CD20, IgM, IgD, CD38 | Blood | 12 | |
| CD19 +IgD +CD27 -CD38 + | Spleen/blood | 20 | |
| CD19 +CD38 ++CD24 ++ | Spleen/blood | 20 | |
| CD24 highCD38 high | Blood, SLO | 85 | |
| CD38 ++CD10 +IgD + | Blood | 88 | |
| Naïve B cell | HLA-DR, CD19, CD20, IgM, IgD | SLO/Blood | 12 |
| CD19 +CD27 - | CSF | 21 | |
| CD19 +CD27 -IgD + | Blood | 27 | |
| CD19 +IgD +CD27 + | Spleen/blood | 20 | |
| CD19 +CD27 -IgD + | CSF | 97 | |
| CD27 -IgD + | Blood | 88 | |
| Non class-switched memory B cell | CD19 +IgD +CD27 + | Spleen/blood | 20 |
| Pre-class switched memory B cell | CD27 +IgD + | Blood | 88 |
| Memory B cell | CD19 +CD27 +IgD - | Blood | 27 |
| HLA-DR, CD19, CD20, CD27 | Blood, SLO | 12 | |
| CD19 +CD27 + | CSF | 21 | |
| CD19 +CD27 +CD80 +CD86 + | CSF | 97 | |
| Centroblast | CD19 +CD38 +CD77 +Ki67 +Bcl-2 - | CSF | 97 |
| Centrocyte | CD19 +CD38 +CD77 - | CSF | 97 |
| Post-class witched memory B cell | CD27 +IgD - | Blood | 88 |
| Class-switched Memory B cell | CD19 +IgD -CD27 + | Spleen/blood | 20 |
| Short lived plasmablast | CD19 +CD27 ++CD138 +CD38 +HLA-DR ++ | CSF | 21 |
| Plasmablasts | HLA-DR, CD19, CD20 low, CD27, CD38 | SLO/blood | 12 |
| CD19 +CD27 +CD38 + | Blood | 27 | |
| CD38 ++CD27 ++IgD - | Blood | 88 | |
| CD19 +CD27 +CD38 ++ | Spleen/blood | 20 | |
| CD19 +CD138 ++ | Spleen/blood | 20 | |
| CD19 +CD27 ++CD138 +CD38 ++ | CSF | 21 | |
| CD19 dimCD27 hiCD38 +CD138HLA-DR Ki67 | CSF, blood | 40 | |
| Plasma cells | CD19 +CD27 ++CD138 +CD38 - | CSF | 21 |
| CD19 low, CD27, CD38, CD138 | SLO/blood | 12 | |
| CD38 +CD138 + | Spleen/blood | 20 | |
| CD19 -CD138 + | CSF | 97 | |
| CD19 +CD138 + | Blood | 27 | |
| Bregs cell | IL10, CD27, CD5, CD25, CD86, CD24, CD38 | Blood | 27 |
| CD24 highCD27 + | Blood, SLO | 85 | |
| CD19 +CD24 ++CD38 ++ | Spleen/blood | 20 | |
| CD19 +CD5 +CD1d ++ | Spleen/blood | 20 | |
| Double Negative B cell | CD27 -IgD - | Blood | 88 |
| LLPC | CD19 -IgD -CD27 +CD138 +CD38 Hi | BM | 103 |
| CD19 -CD138 +CD38 Hi | BM | 103 | |
| ASC in CSF | CD19 -CD27 +CD38 +IgG | CSF | 40 |
| B cells in CSF | CD19 +CD138 - | CSF | 21 |
| CD19 dimCD27 hiCD138 +ASC | CSF | 40 |